CHARLES WG EIFRIG
Allopathic & Osteopathic Physicians|Ophthalmology|Retina Specialist LAGUNA HILLS, CA NPI 1306812979
Browse related groups: Allopathic & Osteopathic Physicians|Ophthalmology|Retina Specialist CA Genentech USA, Inc. All categories
General Payments — all program years on this page
$294,221.93
- Category: General Payments
- Program years: PY2018–2024
- Record count: 422
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $53,871.29 across 80 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22,560.00 | 4 |
| Consulting Fee | $21,974.00 | 8 |
| Travel and Lodging | $6,787.10 | 18 |
| Food and Beverage | $2,550.19 | 50 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Genentech USA, Inc. | $36,893.82 | 46 |
| Alcon Research LLC | $11,000.00 | 4 |
| Regeneron Pharmaceuticals, Inc. | $2,529.00 | 2 |
| Beaver-Visitec International, Inc. | $2,100.00 | 1 |
| Alcon Laboratories Inc | $699.76 | 8 |
| Regeneron Healthcare Solutions, Inc. | $214.36 | 4 |
| Astellas Pharma US Inc | $125.57 | 5 |
| Genentech, Inc. | $114.89 | 1 |
| ABBVIE INC. | $63.86 | 3 |
| Sandoz Inc. | $45.15 | 2 |
| Apellis Pharmaceuticals, Inc. | $32.10 | 1 |
| Coherus Biosciences Inc. | $19.96 | 1 |
| Alimera Sciences, Inc. | $19.14 | 1 |
| Astellas Pharma Global Development | $13.68 | 1 |
By program year
Records — PY2024 (80)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.